{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:28:15Z","timestamp":1792978095004,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EB00894"],"award-info":[{"award-number":["EB00894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.biomaterials.2012.07.039","type":"journal-article","created":{"date-parts":[[2012,9,2]],"date-time":"2012-09-02T23:17:26Z","timestamp":1346627846000},"page":"8540-8547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials"],"prefix":"10.1016","volume":"33","author":[{"given":"Yuwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny K.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2012.07.039_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s11095-010-0334-0","article-title":"Localized delivery of antisense oligonucleotides by cationic hydrogel suppresses TNF-alpha expression and endotoxin-induced osteolysis","volume":"28","author":"Dong","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.blo.0000194728.62996.2d","article-title":"The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution","volume":"441","author":"Tanzer","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib3","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/jor.20299","article-title":"Biomechanical evaluation of a new augmentation method for enhanced screw fixation in osteoporotic proximal femoral fractures","volume":"24","author":"von der Linden","year":"2006","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1054\/arth.2002.32169","article-title":"The effect of demineralized bone matrix gel on bone ingrowth and fixation of porous implants","volume":"17","author":"Cook","year":"2002","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2106\/00004623-199508000-00001","article-title":"Enhancement of bone ingrowth by transforming growth factor-beta","volume":"77","author":"Sumner","year":"1995","journal-title":"J\u00a0Bone Jt Surg Am"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jor.1100140609","article-title":"Effect of noninvasive low intensity ultrasound on bone growth into porous-coated implants","volume":"14","author":"Tanzer","year":"1996","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/145749690209100202","article-title":"Treatment of osteoporotic fractures","volume":"91","author":"Larsson","year":"2002","journal-title":"Scand J Surg"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1163\/156856206778366004","article-title":"Injectable PLGA microsphere\/calcium phosphate cements: physical properties and degradation characteristics","volume":"17","author":"Habraken","year":"2006","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib9","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.biomaterials.2005.11.023","article-title":"Calcium phosphate cements: competitive drug carriers for the musculoskeletal system?","volume":"27","author":"Ginebra","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib10","doi-asserted-by":"crossref","first-page":"44105","DOI":"10.1088\/1748-6041\/3\/4\/044105","article-title":"Injectable bioactive calcium-magnesium phosphate cement for bone regeneration","volume":"3","author":"Wu","year":"2008","journal-title":"Biomed Mater"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003086-198106000-00037","article-title":"Calcium phosphate ceramics as hard tissue prosthetics","author":"Jarcho","year":"1981","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.0.CO;2-8","article-title":"Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement","volume":"39","author":"Takechi","year":"1998","journal-title":"J\u00a0Biomed Mater Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0142-9612(00)00252-0","article-title":"Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline","volume":"22","author":"Ratier","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jps.2600840614","article-title":"A\u00a0novel skeletal drug delivery system using self-setting calcium phosphate cement. 9: effects of the mixing solution volume on anticancer drug release from homogeneous drug-loaded cement","volume":"84","author":"Otsuka","year":"1995","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E","article-title":"Transforming growth factor-beta1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in\u00a0vitro","volume":"50","author":"Blom","year":"2000","journal-title":"J\u00a0Biomed Mater Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jbm.a.31831","article-title":"Evaluation of the biocompatibility of calcium phosphate cement\/PLGA microparticle composites","volume":"87","author":"Link","year":"2008","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat Mater"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.biomaterials.2012.07.039_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2106\/00004623-200300003-00013","article-title":"rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)\/calcium-phosphate cement composites","volume":"85-A","author":"Ruhe","year":"2003","journal-title":"J\u00a0Bone Jt Surg Am"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0169-6009(08)80211-5","article-title":"The expression of osteoclast markers on foreign body giant cells","volume":"27","author":"Kadoya","year":"1994","journal-title":"Bone Miner"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.56.7.414","article-title":"Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells","volume":"56","author":"Sabokbar","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2007.01.013","article-title":"Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages","volume":"119","author":"Hirota","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib23","first-page":"928","article-title":"Oligonucleotide-based knockdown technologies: antisense versus RNA interference","volume":"4","author":"Achenbach","year":"2003","journal-title":"Chem biochem"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/CS20050162","article-title":"Short interfering RNA (siRNA): tool or therapeutic?","volume":"110","author":"Cejka","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2011.09.002","article-title":"RNA therapeutics targeting osteoclast-mediated excessive bone resorption","author":"Wang","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib28","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib30","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in\u00a0vitro and in\u00a0vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in\u00a0vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib34","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11095-010-0099-5","article-title":"siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption","volume":"27","author":"Wang","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/mp100374n","article-title":"Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures","volume":"8","author":"Wang","year":"2011","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib36","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/jps.21215","article-title":"Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery","volume":"97","author":"Abbas","year":"2008","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(01)00413-8","article-title":"Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells","volume":"76","author":"Walter","year":"2001","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib38","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.biomaterials.2008.02.012","article-title":"Introduction of enzymatically degradable poly(trimethylene carbonate) microspheres into an injectable calcium phosphate cement","volume":"29","author":"Habraken","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1557\/JMR.1997.0026","article-title":"Sintering of the ultrahigh pressure densified hydroxyapatite monolithic xerogels","volume":"12","author":"Majling","year":"1997","journal-title":"J\u00a0Mater Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3349\/ymj.2007.48.4.653","article-title":"High concentrations of pamidronate in bone weaken the mechanical properties of intact femora in a rat model","volume":"48","author":"Yang","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MED.0b013e328317ca83","article-title":"Osteoporosis: how long should we treat?","volume":"15","author":"Sebba","year":"2008","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A\u00a0delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib44","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"Choung","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib47","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/bm025563c","article-title":"Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery","volume":"3","author":"Wang","year":"2002","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/bip.20978","article-title":"Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA","volume":"89","author":"Jiang","year":"2008","journal-title":"Biopolymers"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/A:1018862827426","article-title":"Preparation and characterization of poly (D, L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA","volume":"16","author":"Capan","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2008.09.039","article-title":"Polymeric nanoparticles for siRNA delivery and gene silencing","volume":"367","author":"Patil","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib51","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1023\/A:1018942118148","article-title":"Determinants of release rate of tetanus vaccine from polyester microspheres","volume":"10","author":"Alonso","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-3659(98)00099-6","article-title":"Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery","volume":"57","author":"Wang","year":"1999","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biomaterials.2006.08.021","article-title":"The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity","volume":"28","author":"Woodard","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib54","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1016\/j.biomaterials.2006.05.022","article-title":"Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles","volume":"27","author":"Link","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2012.07.039_bib55","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.biomaterials.2004.05.010","article-title":"Injectability of calcium phosphate pastes","volume":"26","author":"Bohner","year":"2005","journal-title":"Biomaterials"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961212008344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961212008344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:43:27Z","timestamp":1758901407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961212008344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":55,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0142961212008344"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2012.07.039","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2012.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}